BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 3, 2001
View Archived Issues
Pivotal trials of Sepracor's rapid- and long-acting bronchodilator initiated
Read More
Sibutramine metabolite in phase II for sexual dysfunction
Read More
Sepracor initiates clinical testing of new compound for anxiety
Read More
Forest seeks FDA approval for new calcium channel blocker
Read More
First target from Lexicon's drug discovery program unveiled
Read More
Uriach compound for IBD with unique mechanism of action licensed to Interneuron
Read More
Clinical trial in asthmatics demonstrates bronchoprotective effect for sildenafil
Read More
Clinical data discussed at ERS meeting support use of omalizumab in allergic asthma, rhinitis
Read More
NBI-34060 to move to phase III following positive phase II results
Read More
Promising phase II results obtained for BBR-2778 in non-Hodgkin's lymphoma
Read More
Study on stability of synthetic red blood cell substitute reported successful
Read More
New diagnostic test for mad cow and Creutzfeldt-Jakob disease enters clinical testing
Read More
rSP-C-based surfactant effective in acute lung injury when given as therapeutic lavage
Read More
CNS excitability reduced by rhubarb extracts in rat hippocampal neurons
Read More
ORP150: therapeutic potential in stroke
Read More
Good stability, favorable pharmacokinetics determined for LJP-920
Read More
Key pharmacokinetic findings, integrated phase III data analysis presented in Rome for Cialis
Read More
Pamidronate reduces bone loss in men on prostate cancer treatment
Read More
Teijin describes preparation and use of new chymase inhibitors
Read More
BMS discloses new series and uses of cannabinoid receptor modulators
Read More
Integrin antagonists under early development at Merck KGaA
Read More
Antiulcer agents from Sankyo inhibit H+/K+-ATPase and H. pylori
Read More
Newly claimed Rho kinase inhibitors with wide range of therapeutic applications
Read More
Advanced Medicine discloses new nicotinic acetylcholine receptor modulators and use as analgesics
Read More
MTP inhibitors from Advanced Medicine reportedly useful for atherosclerosis
Read More
Novel compounds for HCV infection patented by Schering-Plough
Read More
